MX2022002533A - Ácidos nucleicos modificados con ligandos 2', síntesis de estos y compuestos intermedios de estos. - Google Patents

Ácidos nucleicos modificados con ligandos 2', síntesis de estos y compuestos intermedios de estos.

Info

Publication number
MX2022002533A
MX2022002533A MX2022002533A MX2022002533A MX2022002533A MX 2022002533 A MX2022002533 A MX 2022002533A MX 2022002533 A MX2022002533 A MX 2022002533A MX 2022002533 A MX2022002533 A MX 2022002533A MX 2022002533 A MX2022002533 A MX 2022002533A
Authority
MX
Mexico
Prior art keywords
ligand
synthesis
nucleic acids
modified nucleic
intermediate compounds
Prior art date
Application number
MX2022002533A
Other languages
English (en)
Inventor
Naim Nazef
Weimin Wang
Original Assignee
Dicerna Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dicerna Pharmaceuticals Inc filed Critical Dicerna Pharmaceuticals Inc
Publication of MX2022002533A publication Critical patent/MX2022002533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a métodos para sintetizar compuestos útiles como agentes de interferencia de ARN potentes y estables, derivados de estos e intermedios de estos.
MX2022002533A 2019-08-30 2020-08-28 Ácidos nucleicos modificados con ligandos 2', síntesis de estos y compuestos intermedios de estos. MX2022002533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962894071P 2019-08-30 2019-08-30
PCT/US2020/048313 WO2021041756A1 (en) 2019-08-30 2020-08-28 Ligand-2'-modified nucleic acids, synthesis thereof and intermediate compounds thereof

Publications (1)

Publication Number Publication Date
MX2022002533A true MX2022002533A (es) 2022-06-02

Family

ID=72433052

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002533A MX2022002533A (es) 2019-08-30 2020-08-28 Ácidos nucleicos modificados con ligandos 2', síntesis de estos y compuestos intermedios de estos.

Country Status (12)

Country Link
US (1) US20220306679A1 (es)
EP (1) EP4021915A1 (es)
JP (1) JP2022545745A (es)
KR (1) KR20220071982A (es)
CN (1) CN114867733A (es)
AU (1) AU2020336121A1 (es)
BR (1) BR112022003861A2 (es)
CA (1) CA3149775A1 (es)
IL (1) IL290940A (es)
MX (1) MX2022002533A (es)
TW (1) TW202122113A (es)
WO (1) WO2021041756A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024112877A1 (en) * 2022-11-23 2024-05-30 Eli Lilly And Company Methods of synthesizing a targeting ligand-conjugated nucleotide phosphoramidite

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432272A (en) 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
US6218108B1 (en) 1997-05-16 2001-04-17 Research Corporation Technologies, Inc. Nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor
US20070265220A1 (en) 2004-03-15 2007-11-15 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
US8084599B2 (en) 2004-03-15 2011-12-27 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
US20080213891A1 (en) 2004-07-21 2008-09-04 Alnylam Pharmaceuticals, Inc. RNAi Agents Comprising Universal Nucleobases
WO2007030167A1 (en) 2005-09-02 2007-03-15 Nastech Pharmaceutical Company Inc. Modification of double-stranded ribonucleic acid molecules
EP3865576A1 (en) 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids

Also Published As

Publication number Publication date
EP4021915A1 (en) 2022-07-06
BR112022003861A2 (pt) 2022-05-24
AU2020336121A1 (en) 2022-03-24
US20220306679A1 (en) 2022-09-29
JP2022545745A (ja) 2022-10-28
TW202122113A (zh) 2021-06-16
IL290940A (en) 2022-04-01
CA3149775A1 (en) 2021-03-04
CN114867733A (zh) 2022-08-05
KR20220071982A (ko) 2022-05-31
WO2021041756A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
MY148253A (en) Azaadamantane derivatives and methods of use
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
DE602005020185D1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2006112742A3 (en) PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
TW200740729A (en) Methods for preparing glutamic acid derivatives
MX2022002533A (es) Ácidos nucleicos modificados con ligandos 2', síntesis de estos y compuestos intermedios de estos.
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
ATE457982T1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
DK1102765T3 (da) Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
PL378118A1 (pl) Oksatiinokarboksyamisy
DE50303586D1 (de) Methylthiophencarboxanilide
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
TW200724523A (en) The manufacturing method of prostaglandin F derivatives and the novel intermediates thereof
MX2021007505A (es) Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3.
ATE417055T1 (de) Steroid modifizierte solatriosen
EA200600360A1 (ru) Δ-d-гомостероиды с андрогенным действием